Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none
- PMID: 20508897
- DOI: 10.1160/TH10-02-0104
Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none
Similar articles
-
Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.Int Angiol. 2008 Aug;27(4):333-43. Int Angiol. 2008. PMID: 18677297 No abstract available.
-
Antithrombotic therapy in peripheral artery disease.Vasc Med. 2016 Apr;21(2):156-69. doi: 10.1177/1358863X15622987. Epub 2016 Jan 28. Vasc Med. 2016. PMID: 26823456 Review.
-
[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Lakartidningen. 2008. PMID: 19006862 Swedish. No abstract available.
-
[Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].Lakartidningen. 2008 Sep 10-16;105(37):2472-3. Lakartidningen. 2008. PMID: 19006861 Swedish. No abstract available.
-
Antithrombotic therapy in peripheral arterial disease.Clin Geriatr Med. 2006 Feb;22(1):183-98, x. doi: 10.1016/j.cger.2005.09.005. Clin Geriatr Med. 2006. PMID: 16377474 Review.
Cited by
-
The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome.Rheumatol Int. 2014 Nov;34(11):1599-605. doi: 10.1007/s00296-014-2996-0. Epub 2014 Mar 27. Rheumatol Int. 2014. PMID: 24671503 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical